George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Legin. The results of the 3,000 person live trial by ulster university which validates the efficacy of the test at 98.6% is new information. Not known previously. The fact that such a large sample size trial on live, real samples still achieved over the 98% bar is a very important big step forward to mass rollout.
If that figure had come in at 97.8% then the RTC would be back to the drawing board and we’d be looking at very different headlines and undoubtedly an RNS to say the test failed it’s first big trial with the resultant shafting of the sp.
The 98.6% accuracy notified in the design freeze was only achieved using a small (30 I think) sample size of library blood samples. Not conclusive.
This is different. This is 3000 patients using the test and sending a blood sample that the test performance has been checked against. This is a big positive result which conclusively proves the efficacy of the test.
The Telegraph article was retweeted by Professor Tara Moore who ran the trial at Ulster University.
This result is great news. New news. Proof of efficacy for mass rollout of home use.
PHE validation and gov orders coming now.
Not *tomorrow but Monday obviously. Today feels like a Sunday. :)
Ulster University were brought into the consortium late in the piece and it’s they who have undertaken this 300 sample study to verify the accuracy figures in the design freeze RNS, which were on a smaller sample size.
Verification of the 98%+ accuracy figure on this larger sample size is extremely important because 98% is the bar figure for confidently testing en masse whole populations. Anything below that has been rejected for that reason.
This further verification will now give PHE added confidence to verify the test and for the Gov to proceed with orders.
This larger sample verification is the information we did not previously have from the design freeze RNS and if anything warrants further regulatory notification then this could be it.
The company might wait for the official PHE approval if they know it is now close.
In short I’d say if we dont get an RNS tomorrow to inform the market of the results of this survey then it will come within days in the form of PHE approval.
Meanwhile, the extra publicity is welcome and only a taster of the global mediafest to come when the tests are rolled out. Everybody will be talking about their results and social media will be buzzing with pictures of them, plus the red tops will have photos of celebrities who test positive for antibodies and the whole antibody/immunity discussion will take centre stage and move to another level entirely.
Just days or weeks away now. GLA.
Global media coverage taking off I see.
No doubt BBC and Sky will be onto it today.
Made the front page of the physical Telegraph too.
People will be googling this today and finding out that there’s only one listed company involved.
Gov rhetoric on antibody testing and immunity will change very soon when they want us to stop distancing and get back to normal. That’s Oct/Nov according to Boris. The entire direction of sentiment around antibodies and immunity and antibody testing will flip within weeks now.
Be ahead of the game. Omega and this ABC19 home Antibody Test will blow the doors off very soon now. This level of publicity is just the start.
on antibody testing and immunity.
If you hadn’t noticed, Politicians tend to lie and tell us what they want us to know in order to manipulate us into compliance with whatever behaviour they require at any given time.
Currently they want a population compliant with distancing and Covid regs. That’s why they banned all these Superdrug antibody tests when they started selling out and everyone wanted them. They don’t want people acting disobediently claiming they are immune. Not yet. They’re not ready.
The story will change over coming months.
Adaptation of Elisa from venous to capillary blood draw could be massive.
The venous draw version of the Elisa lab test has been CE marked. This is a highly accurate test but has all the drawbacks of requiring a phlebotomist to draw a venous blood sample to send to a lab for testing.
Omega are currently working on an adaptation of this test that would allow it to utilize a capillary blood draw. This modified device should be approved early August according to Colin.
This is the one that will blow the doors off! GLA.
I don’t think profits will be held back by moralistic endeavors.
For evidence of this you only have to look at the infectious disease CD4 tests for HIV which are sold into African countries for $4 per test at 70% margin.
Developing nations use foreign aid to buy the tests anyway, it gives the despots something to spend our money on rather than Kalashnikovs and landmjnes.
Omega are not a charity and will make good margin on everything they sell. Even if the RTC ABC19 tests are sold cheaply to the public then that cost will be subsidized by the government and omega will still make good margin. UK gov may well supply them to the public for less than they pay for them from omega. Subsidized.
Imminently!
PDMSPiper
Posted in: ODX
Posts: 1,914
Price: 49.95
Strong Buy
Expecting Gov order for Mologic Elisa tests anytime.28 Jun 2020 20:43
As well as the Gov orders for the RTC LF Antibody tests, I’m also expecting a sizeable “surprise” Gov order for the Mologic Elisa Antibody tests.
1.) The test is highly accurate, assessed at well over the 98% accuracy bar for mass testing of whole populations.
2.) The bad publicity last week was around the lack of accuracy of the Roche Elecsys lab tests that weren’t sufficiently tested by PHE and are far from the claimed 100%.
3.) Gov order for the UK made Elisa tests would fix the Roche poor PR issue and be be a further coup for Boris as it was developed using Gov funding.
4.) The Elisa test has already been manufactured at scale in “verification batches” by Omega at Littleport.
5.) It is already CE marked.
6.) BoD wouldn’t have agreed to reserve valuable capacity for up to 46,000 Elisa tests per day if there wasn’t a ready market for them.
7.) Elisa test currently being assessed by Public Health England.
I’m hopeful and expectant that we’ll get a surprise notification of a large uk gov order for the Mologic Elisa tests and Littleport will ramp up production to 46,000 per day. The market isn’t expecting it. A nice gov order for 10 million would be 7 months production and set the cat amongst the pigeons here.
I say 10 million because that’s how many Roche Elecsys tests they ordered and it doesn’t seem to be working out as well as expected. Let’s see.
Lots of possibilities for news here and lots of *unexpected* news that will take many by surprise and they’re always the best ones for the share price!
I was under the impression all vaccines stimulate the production of antibodies. That’s how they work. They produce a neutralized non dangerous form of the virus that will still be recognized by the immune system and cause production of antibodies.
That’s why it’s so dangerous to produce a vaccine because it’s a fine line: too safe, too dormant and the immune system will not recognize it and it won’t work and too severe and it can be as bad as having the actual virus and possibly kill the patient.
No antibody immunity then no vaccine!
This nhs guide on how the flu vaccine works is a good little 5 minute read ....
https://www.nhs.uk/conditions/vaccinations/how-flu-vaccine-works/
As I said. Form an investment strategy around what the Guardian says at your peril.
As for Spain, they’ve used the cheapo rubbish Chinese tests that have been rejected everywhere else.
The Spanish are motivated to milk Covid for all its worth because they are pushing Brussels for massive bailouts. They’ve just instigated a policy of mandatory mask wearing in all outside spaces in Murcia and other regions. Masks have been obligatory in shops in Spain for months. They’re pushing the fear factor constantly. I know I live there.
Lots of media propaganda and political agendas around all this. I’ve made a judgement that it’s bull sheet, and am sticking with that strategy.
Antibodies are providing at least six months of immunity to reinfection thus far and will undoubtedly provide ongoing resistance. That’s why there are now programs of antibody plasma transfusions for infected patients.
Not going to argue any more about it. Gov strategy is there on the websites and I’ve got mine and nothing’s changed for me.
GLA DYOR.
Just look on the Gov antibody test TPP page where it says “Target Population”.
Last updated 10th July. What does it say?....
“Target population
Desired: people who need to know that they are immune to SARS CoV-2
Acceptable: people who may have recovered from suspected or confirmed SARS CoV-2 infection or may have previously developed an asymptomatic infection”
https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/target-product-profile-antibody-tests-to-help-determine-if-people-have-recent-infection-to-sars-cov-2-version-2
Nothing has changed in relation to antibodies and our immune systems either. Unless we have suddenly evolved into another species with some other mechanism to protect us from disease.
The scientists knocking it are most likely doing so to push for funding for their own research. Scientists largely say what they are paid to say or whatever benefits them and newspapers like the Guardian will publish it because they know immunity and antibody testing is gov strategy and they’ll push anything that gives this government a hard time, same with many of the other rags and same with the BBC.
Construct an investment strategy around what the media says at your peril!!!
For all their bashing and shouting not one media outlet globally has managed to bring forward a verified case of reinfection. Don’t you think if Terry from Tyneside had caught it twice he’d be on the front page of the daily mirror in a flash, or even Bert from Bombay. They are frantically searching for a verified reinfection globally. It would be a massive scoop. Headline news. There aren’t any.
Gov policy on mass antibody testing is still assuming that antibodies provide immunity. It’s there on the gov website, clear as day, on a page that was updated as recently as 10th June.
Nothing’s changed with regard to gov strategy on antibodies and immunity. Nothing.
When you buy into an investment strategy like Omega and Covid testing, if you’ve done research you should fully understand that you are buying into a story.
In order for full value to be attained you have to hold the stock to allow the story to play out.
I can’t understand the mentality of people who are whining, moaning and selling out in a huff when the story is only on the first chapter. We haven’t even had the start of the mass antibody testing program as detailed in the five pillar strategy and that’s what you bought in for surely? That’s what I bought in for. That’s what we’ve been discussing all along. It’s yet to happen but it undoubtedly will. It’s there on the gov strategy website.
If people don’t want to wait for forecast events to come to fruition then there isn’t much to be done. Your call.
I didn’t even think there was anything wrong with yesterday’s RNS. A load of whining about nothing. It was obvious that the numbers talked about are weekly. The Mologic Elisa test production target is 46,000 units per week. All the numbers in the presentation are per week.
Happy to hold to let the full story play out. Not expecting anything new from the presentation tonight. I won’t even be watching it. I’ve listened to the presentation on the website and am happy with it. This is just for whining investors who have been complying they need “reassurance” or something to help them “keep faith”, like it’s the fkn moonies. Lol @ the knobbers.
Holding for £300mill Mcap and the conclusion of the strategy. Meanwhile, going out for a nice lunch. Happy days :)
....MHRA and PHE approval, poss UK gov orders and India orders plus news of breaking into other global markets using existing CD4 distribution network.
Very informative article all about the partnership between Omega and Mologic with the background story and an interview with Colin King CEO. It’s from April but all still very relevant.....
“King claims the Omega-Mologic antibody test is as close to perfection as humanly possible, with 98% accuracy — citing a successful collaboration as the reason, given the raw materials used to make them must be of high enough quality to return such results.”
https://www.nsmedicaldevices.com/analysis/uk-covid-19-antibody-testing/
The Elisa test is already CE marked and being assessed by Public Health England, PHE. Matt Han**** actually said in one of the briefings that they were assessing an Elisa antibody test. Mologic fully intend to market their Elisa tests for commercial sale in Europe. Could still be sold into U.K. ....
“Dr Joe Fitchett, Medical Director, Mologic: “Alongside the Liverpool School of Tropical Medicine and St George’s, University of London we launched a radically open, responsive, and rapid validation model to accelerate the submission of our COVID-19 diagnostics to Public Health England and for regulatory approval. Our laboratory and point-of-need tests will allow individuals to detect whether they have antibodies to COVID-19 and bring us one step closer to improving access to high quality diagnostics.”
https://mologic.co.uk/mologic-launches-new-lab-based-covid-19-antibody-tests/
If you’d said at the start of the post it was only 96% accurate I could have saved 2 minutes of my life.
Derampers are now desperate to encourage people to sell. They all think they’re Gordon gecko and it makes them feel capable if they can get in under placing price. It’s been possible to buy at 39 but there’s been nothing on at size.
These clowns know they’ve only got until after the meeting on Friday when everything is voted through and that’s the end of the uncertainty and its all up from there.
If they haven’t loaded up by Friday when the vote RNS drops they’ll be buying higher and they know it.
All blue from Friday. :)
Cutting vat for the hospitality industry obviously allows them to keep 15% more of their profits as it’s highly unlikely the cost saving will be passed on to the customer.
Beer and food in a pub will still cost the same. The gross charge per night in a hotel will still cost us the same. It’s a small financial recompense for business. It doesn’t fully compensate for damage done due to reduced capacity and months being closed but every little helps. That’s the point of it.
I had a forecast of £300 million Mcap minimum by the end of the year and that was based on the company’s previous production capacity of 1 Million tests per week/ 50 Million per year.
Capacity now 2 Million tests per week/100 Million per year so my Mcap forecast should go up to £500mill minimum but I’m happy to stick with my £300mill target for now and see where it goes.
Meanwhile, I’ll be at the beach or at the bar while this one is gently cooking in the oven. Happy days. Chat soon.
Change my nappy. Why would that be you fool. The main risk here was not achieving the accuracy bar for the LF RTC test. That’s been achieved. All we’ve had is more and more positive news to derisk this stock more and more.
I was chilled with it 2 months ago and I’m even more chilled and confident with it now.
All I can do is analyse the fundamentals and make a decision based on the potential which I’ve done. Nothing has happened to affect that in a negative manner. In fact it’s got much better.
I can’t control what the market or the MMs do with the share price but I’m confident in my assessment of this stock and so I’m happy.
Nappy not required. Chill out and come back in a week or two. Stress is bad for your health. Cheers.
LoL at you bedwetters. Ha.
Put your money in the post office.
Enjoying a chilled vino by the beach. Don’t see why there’s so much whining. They only raised £11mill. It isn’t even much dilution.
The play is now totally derisked. Not even worth reading this board of ramblings from **** pants children.
Delete your accounts and buy premium bonds. Kn088ers. Lol.